A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration | MicrobiomeTrials
A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-03-09Est. Completion: 2029-08-21
Enrollment target: 272 participants
Locations
Salehi Retina Institute, Huntington Beach, California, United States
Retinal Consultants Medical Group Inc, Sacramento, California, United States
California Retina Consultants, Santa Barbara, California, United States
Advanced Research LLC, Boynton Beach, Florida, United States
Advanced Research LLC, Deerfield Beach, Florida, United States
Retina Vitreous Associates of Florida, St. Petersburg, Florida, United States
Opthamalic Consultants of Boston, Boston, Massachusetts, United States
NJ Retina, Toms River, New Jersey, United States
Erie Retina Research LLC, Erie, Pennsylvania, United States
Retina Consultants TX Rsrch Ctr, Bellaire, Texas, United States
Retina Consultants of Houston PA, Houston, Texas, United States
Retina Consultants of Texas, Katy, Texas, United States
Novartis Investigative Site, Albury, New South Wales, Australia
Novartis Investigative Site, Parramatta, New South Wales, Australia
Novartis Investigative Site, Strathfield, New South Wales, Australia
Novartis Investigative Site, East Melbourne, Victoria, Australia
Other microbiome trials you might be interested in